These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36103616)

  • 21. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.
    Ma J; Waxman DJ
    Mol Cancer Ther; 2008 Dec; 7(12):3670-84. PubMed ID: 19074844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of selected patents for cancer therapy targeting tumor angiogenesis.
    Kirstein MN; Moore MM; Dudek AZ
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):153-61. PubMed ID: 18221033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
    van der Meel R; Symons MH; Kudernatsch R; Kok RJ; Schiffelers RM; Storm G; Gallagher WM; Byrne AT
    Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiangiogenic therapy using nanotechnological-based delivery system.
    Kanwar JR; Mahidhara G; Kanwar RK
    Drug Discov Today; 2011 Mar; 16(5-6):188-202. PubMed ID: 21262383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting.
    Handa M; Beg S; Shukla R; Barkat MA; Choudhry H; Singh KK
    J Control Release; 2021 Dec; 340():48-59. PubMed ID: 34695523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boosting Checkpoint Immunotherapy with Biomaterials.
    Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L
    ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine.
    Alsaab HO; Al-Hibs AS; Alzhrani R; Alrabighi KK; Alqathama A; Alwithenani A; Almalki AH; Althobaiti YS
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics.
    Abdalla AME; Xiao L; Ullah MW; Yu M; Ouyang C; Yang G
    Theranostics; 2018; 8(2):533-548. PubMed ID: 29290825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiangiogenic chemotherapeutic agents.
    Schirner M
    Cancer Metastasis Rev; 2000; 19(1-2):67-73. PubMed ID: 11191065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic therapy.
    Albo D; Wang TN; Tuszynski GP
    Curr Pharm Des; 2004; 10(1):27-37. PubMed ID: 14754403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in silica based nanoparticles for targeted cancer therapy.
    Yang Y; Yu C
    Nanomedicine; 2016 Feb; 12(2):317-32. PubMed ID: 26706409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer.
    Mukherjee A; Madamsetty VS; Paul MK; Mukherjee S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smart Nanotherapeutic Targeting of Tumor Vasculature.
    Li Z; Di C; Li S; Yang X; Nie G
    Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.
    Zhang X; He Z; Xiang L; Li L; Zhang H; Lin F; Cao H
    Drug Des Devel Ther; 2019; 13():1357-1372. PubMed ID: 31118572
    [No Abstract]   [Full Text] [Related]  

  • 36. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
    Layek B; Sadhukha T; Panyam J; Prabha S
    Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.
    Welti J; Loges S; Dimmeler S; Carmeliet P
    J Clin Invest; 2013 Aug; 123(8):3190-200. PubMed ID: 23908119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic therapy for cancer: an update.
    Al-Husein B; Abdalla M; Trepte M; Deremer DL; Somanath PR
    Pharmacotherapy; 2012 Dec; 32(12):1095-111. PubMed ID: 23208836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of antiangiogenic chemotherapy regimens].
    Takahashi H; Kondo T
    Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):237-43. PubMed ID: 11904987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
    Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
    Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.